Your session is about to expire
← Back to Search
Fisetin for Coronavirus
Study Summary
This trial will test whether Fisetin can help prevent the progression of coronavirus and its complications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 55 Patients • NCT04771611Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the maximum capacity of participants in this research endeavor?
"At present, this clinical trial is not accepting new patients. Initially posted on August 3rd 2020 and most recently edited January 17th 2022, an individual seeking to take part in a medical study may consider one of the 1011 trials recruiting participants with covid-19 or 6 studies involving Fisetin that are currently enrolling volunteers."
Has Fisetin previously been tested in any other research studies?
"Currently, 6 clinical trials are being conducted on Fisetin yet none have advanced to Phase 3. The medical research is primarily based in Vail, Colorado with a handful of other locations participating in the testing."
Has Fisetin obtained clearance from the US Food and Drug Administration?
"From the data available, Fisetin has been assigned a safety rating of 2 on our 1 to 3 scale. This is due to Phase 2 trial results which demonstrate some evidence supporting its security but no efficacy information."
Is it currently feasible to enroll in this scientific experiment?
"This trial is no longer recruiting. It was originally posted on August 3rd 2020 and last updated on January 17th 2022. However, if you are looking for alternative studies to participate in, there are 1011 trials accepting participants with covid-19 as well as 6 clinical trials that require candidates for Fisetin testing."
Share this study with friends
Copy Link
Messenger